noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

Pharmaceuticals and Biotechnology

Spanish Agency for Medicines and[...]

La AEMPS informa del cese de comercialización, retirada del mercado y[...]
Synakis Corp

Synakis Co-Founder Molly Shoichet Elected a Fellow of the National[...]
Synakis Corp

Synakis Advances to Building a Biotech Venture Pitch Competition

Economy, Business and Finance

Synakis Corp

12/15/2022 | Press release | Archived content

Synakis Selected for Medicine by Design’s Building a Biotech Venture Program

Synakis Selected for Medicine by Design's Building a Biotech Venture Program

December 15, 2022

Synakis has been selected to participate in Medicine by Design's Building a Biotech Venture Program. Synakis will join the 10-team program from January-March 2023. At the end of the program, six teams will be selected to participate in a pitch competition and compete for $25,000 in funding.

Synakis Corp published this content on December 15, 2022, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 02, 2026 at 06:18 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]

Back

View original format